Uppsala University

IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere

A handful of academic groups in Europe and the US are using high-throughput (HT) ex vivo screening to test the sensitivity of individual patient tumors to hundreds of combinations of cancer drugs –

Pharmalink AB , a specialty Scandinavian biotech focused on orphan and niche products, has raised SEK96 million ($15 million) in a Series C financing round for use in pivotal trials for its Nefecon

IN VITRO DIAGNOSTICS Banyan Biomarkers Inc. TBI test maker Banyan Biomarkers raises $6mm in Series A financing Banyan Biomarkers Inc. , which focuses on neurological molecular diagnostics, has